tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
Advertisement

Protagonist Therapeutics (PTGX) Similar Stocks

Compare
687 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Protagonist Therapeutics
$56.25
$3.50B
78.94
35.54%
10 Buy
0 Hold
0 Sell
Strong Buy
ACADIA Pharmaceuticals
$24.97
$4.27B
18.83
60.37%
11 Buy
5 Hold
1 Sell
Moderate Buy
Viking Therapeutics
$24.36
$4.50B
-63.17%
17 Buy
2 Hold
0 Sell
Strong Buy
Merus
$63.65
$4.99B
18.51%
13 Buy
0 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$54.16
$5.43B
10.37%
11 Buy
6 Hold
0 Sell
Moderate Buy
Scholar Rock Holding
$30.12
$3.03B
223.18%
9 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PTGX
Protagonist Therapeutics
56.25
14.75
35.54%
ACAD
ACADIA Pharmaceuticals
24.97
9.40
60.37%
VKTX
Viking Therapeutics
24.36
-41.78
-63.17%
MRUS
Merus
63.65
9.94
18.51%
CRSP
Crispr Therapeutics AG
54.16
5.09
10.37%
SRRK
Scholar Rock Holding
30.12
20.80
223.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis